Jianwei (Jerry) Fang, Rui Yang, Ke Dong, Chen (Cissy) Chen and Yongan Shen of Zhong Lun Law Firm continue their analysis of China’s evolving export control regime. Here, the authors focus on recent development in China’s rare-earth export control framework, in particular, the scope of the one-year suspension of the Rare Earth Measures, ongoing compliance obligations, and potential legal risks for foreign businesses
Shanghai issues typical cases on patient and consumer data leakages. | Some rare earth shipments accelerated following China’s issuance of general export licenses. | China’s securities regulator strengthens rules to combat financial fraud in listed companies
Record Chinese biotech licensing deals amidst gradual shift to NewCo model; China leading in European plug-in hybrids sales while industry lobbies for hybrids; and Saudi Arabia goes all-out to attract Chinese tech investment and expats
U.S. House panel intensifies scrutiny of Morgan Stanley over IPO linked to Uyghur forced-labor entity. | Three foreign carmakers obtain approval to deploy AI chatbots in cars in China. | Indonesia considers issuing renminbi-denominated bonds amid China’s push against dollarization.
Beijing Municipality considers adopting other negative lists of outbound data transfer programs nationwide | Court rules that AI prompts are not “works” hence not copyright-protected. | U.S. coffee giant shifts to joint venture model amid slowing growth and fierce competition in China.
China’s self-driving cars need to adapt to EU tech compliance regulations | Winning bids for drug procurement contracts to be kept confidential as regulators aim to balance competition and sustainability | China adds U.S.-linked ETFs in latest expansion of cross-border ETF Connect program
Jianwei (Jerry) Fang, Rui Yang, Ke Dong, Songyang Wang, Jiaying Jiang and Yongan Shen of Zhong Lun Law Firm analyze China’s latest strengthened enforcement in export control and countermeasure actions. The authors examine how newly-announced restrictions and countermeasures reflect China’s strategy of reciprocal regulatory response, the expansion of its extraterritorial jurisdiction through origin-based control mechanisms, and the increasing compliance challenges for foreign businesses operating in or with China
Increase in venture capital into China marks recovery of sector | U.S. state attorneys general target TP-Link, Lorex and Temu in widening push over privacy and security | China’s investments into Central Asia create integrated economic ecosystems
U.S. export controls extended to subsidiaries of Chinese companies | PBOC broadens foreign access to its bond market by aligning China’s repo framework with global standards | U.S. court rules that DJI failed to counter proof of its military links.
U.S. pharma raises alarm over Trump’s proposed measures against Chinese drugs; China clarifies the type of employees to be bound by non-compete clauses; and Some stablecoin issuers complain that Hong Kong’s regime is too stringent.
